Ethacrynic Sodium
Product Images NDC 68682-012

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethacrynic Sodium (NDC 68682-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

INTRAVENOUS ETHACRYNATE SODIUM is a solution that comes in 50 mg vials containing Ethacrynic. It is used to prepare intravenous solutions and usual dosage is 50-100mg per the instructions on the accompanying package. The container is hermetically sealed and only allowed by authorized personnel.*

FDA Label Image

Image 02

This is the description for Ethacrynic Acid Tablets manufactured and distributed by Oceanside Pharmaceuticals. Each tablet contains 25 mg of ethacrynic acid and is available in a package of 100 tablets. This medication is meant for prescription only and should be stored in a tightly closed container at room temperature. The package is not child resistant and should not be dispensed as such. The medication insert should be consulted for the correct dosage. This medication is manufactured in Steinbach, Canada by Bausch Health Companies.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.